mitazalimab 
GtoPdb Ligand ID: 13692
|
Synonyms: ADC-1013 | ADC1013 | JNJ-64457107 | JNJ64457107
Compound class:
Antibody
Comment: Mitazalimab (formerly JNJ-64457107, or ADC-1013) is an anti-CD40 monoclonal antibody. It binds CD40 on dendritic cells (DC) as a mechanism to activate T cell-dependent anti-tumour immunity [2]. Intratumoural administration of mitazalimab induces immunostimulant activity and initiates Fc-effector functions against tumour cells.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
| Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License